Jianfeng Group has been listed for 25 years.
Release time:
2020-08-14
Jianfeng Group has been listed for 25 years
Zhejiang Daily reporter Liu Wei
Editor's note: 1993 7 28 , Jianfeng Group's public shares were listed on the Shanghai Stock Exchange, becoming a milestone in the development history of Jianfeng 60 years. A few days ago, the "Zhejiang Daily" published an article, the peak 25 years to stick to the main business, innovation and development of the deeds of the report. This newspaper is reproduced.
7 , Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "Jianfeng Group"), located at 88 Wujiang East Road, Jinhua City, celebrated the 34th anniversary of the company's listing 25.
Jianfeng Group is not only the first listed company in China's cement industry, but also the earliest listed company in Zhejiang Province that is still listed on A shares. Judging from the history of 25 years, although A shares have experienced several rounds of bulls and bears, the stock price trend of Jianfeng Group has remained in the overall stable upward channel.
Don't chase hot spots, avoid delinquency
"After the listing of the Peak Group in order to overcome the cyclical characteristics of the cement industry, but also carried out some diversification exploration. At that time, there were many opportunities to make money, but many of our areas were briefly tried and immediately quit, the overall or around the two main businesses." Jianfeng Group Chairman Jiang Xiaomeng told reporters.
Any project that makes money is a common problem for many enterprises after listing. In particular, some listed companies often rub against the concept of hot spots, which leads to sharp rise and fall of stock prices and finally ends up in a feather.
1994 November , Jianfeng Group successfully bought Jinhua MSG Factory, a state-owned enterprise, with 1400 yuan and began to produce soy sauce and rice vinegar. In the same year, the peak communication cable Co., Ltd. was completed and put into operation. "At that time, there were many fields, including ceramics, electronic instruments, mineral water, toll roads and so on." Jiang Xiaomeng recalled, "But we finally found that these were not what the peak really needed, and we quickly withdrew." Jianfeng Group will eventually break the direction of the pharmaceutical industry.
In 1998 8 , Jianfeng Group purchased the then Jinhua Biochemical Pharmaceutical Factory and established Jianfeng Pharmaceutical Co., Ltd. on this basis. At present, the operating income of the peak pharmaceutical sector has exceeded 40%, becoming one of the main businesses of the peak group. "At present, our two major businesses, cement and medicine, account for 90% of the revenue. In addition, there are two major businesses, health and trade logistics, both of which are related to the main business." Jiang Xiaomeng concluded that the key to the development of the peak lies in not chasing hot spots, not robbing quick money and sticking to industry. In recent years, there have been many examples of listed companies going from real to virtual. Jianfeng Group has also carried out a series of investment mergers and acquisitions in recent years, but it has always focused on the two main businesses, which also makes the company's performance improve steadily, so as to avoid the ups and downs of the company's efficiency.
A listed companies do not pay dividends to shareholders for a long time, which is called "iron rooster" by the market ".
25 , the total assets and net assets of Jianfeng Group increased nearly 30 times and 28 times respectively. 2017 The company realized net profit attributable to owners of the parent company 3.48 .9 billion yuan, and earnings per share reached 1.01 yuan, a record high since listing. What is even more rare is that the company has continuously given back to investors. In the past 10 years, 9 has paid cash dividends. Since Jianfeng Group went public, its accumulated cash dividends have reached .7 billion yuan. "Listed companies should develop steadily, while insisting on giving investors returns and balancing cash dividends with the long-term development of the company. This is a win-win situation for investors to share the dividends of corporate growth and for the company to continue to develop healthily." Jiang Xiaomeng said.
5 , after the "New Country Nine Articles" first proposed "encouraging listed companies to establish a market value management system", market value management has become the focus of the capital market: listed companies hope to use this To achieve industrial transformation and upgrading, shareholders hope to maximize value, but in actual operations, there have been many violations of laws and regulations in the name of "market value management. In recent years, a number of listed companies have been investigated by the CSRC because of market manipulation and insider trading in the name of market value management.
2020 . "As the listed company with the longest listing history of A shares in Zhejiang Province, we feel the pressure and responsibility." Jiang Xiaomeng said, "there are many listed companies that are better than us, and the peak should also learn from the excellent listed companies and strive to realize the dream of 'one hundred years' peak."
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page